NAV-002 (Navrogen)(NAV-002 (Navrogen)) - 药物靶点：FOLR1_ …
NAV-002 (Navrogen): 一种FOLR1调节剂药物，由Navrogen, Inc. (Navrogen, Inc.)公司最早进行研发，目前全球最高研发状态为临床前，作用机制: FOLR1调节剂(叶酸受体α调节剂)，治疗领 …
ALNAV 2025 - MyNavyHR
002/25: 2025 active duty fund drive in support of the navy-marine corps relief society: 01/15/2025: 001/25: policy governing investigation and handling of formal sexual harassment complaints …
Pipeline - Navrogen
NAV-201 is a small-molecule compound that binds to CD16/Fc Receptor and activates NK cells, which go on to kill tumor cells (figure). NAV-201 can restore NK cell activity in the presence of …
NAV-002 (NAV-002) - 在研适应症：自身免疫性疾病_专利_临床_ …
NAV-002，由Navya Biologicals Pvt Ltd. (Navya Biologicals Pvt Ltd.)公司最早进行研发，目前全球最高研发状态为临床前，治疗领域: 免疫系统疾病，在研适应症: 自身免疫性疾病，在研机构: …
NAV-002 (Navrogen) - Drug Targets, Indications, Patents - Synapse
NAV-002 (Navrogen): a FOLR1 modulators Drug, Initially developed by Navrogen, Inc., Now, its global highest R&D status is Preclinical, Mechanism: FOLR1 modulators (Folate receptor …
NAV-002 - Drug Targets, Indications, Patents - Synapse - Patsnap
Understand key drug designations in just a few clicks with Synapse. NAV-002, Initially developed by Navya Biologicals Pvt Ltd., Now, its global highest R&D status is Preclinical, Therapeutic …
NAV | Official Store
Shop official NAV vinyl, CDs, t-shirts, hoodies, longsleeves, accessories, digital music downloads, and more. OMW2 REXDALE, the long-awaited album new album from NAV, releases March …
Navya Biologicals Pvt Ltd. (Navya Biologicals Pvt Ltd.) - 药物管线_ …
了解Navya Biologicals Pvt Ltd. (Navya Biologicals Pvt Ltd.)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:肿瘤，免疫系统疾病，技术平台:小分子化药，药物:NAV-013，NAV …
Supersedes: Marine Notice NAV-002, dated 06/12 . The following changes have been included: It updates website and contact information for National Geospatial-Intelligence Agency. …
NAVADMIN 2025 - MyNavyHR
SYBIL STOCKDALE OMBUDSMAN OF THE YEAR AWARD.